Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9af4d89807e0db8298692dffeabf875 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-36 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
filingDate |
2018-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_287ea5fb8f7266cb6cb7fb254d96c9c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9644e262164afc104ac15f5b89f71393 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c4c3d155d3269fd93a838aba1947432 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f91a7f8d98c44e0ee822b7713ff8c3bd |
publicationDate |
2019-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
TW-201930289-A |
titleOfInvention |
Crystalline type of N-(4-(4-(cyclopropylmethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide |
abstract |
This article provides the amorphous and crystalline hemisulfate forms of the following formula. . Also provided are pharmaceutical compositions containing these amorphous and crystalline hemisulfate forms, methods for their manufacture, and their use for treating conditions associated with pyruvate kinase, such as pyruvate kinase deficiency. |
priorityDate |
2017-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |